The prevalence and predictors of extended spectrum B-lactamase urinary tract infections among emergency department patients: A retrospective chart review
- 1 November 2021
- journal article
- review article
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 49, 304-309
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Epidemiology, risk factors and comorbidity for urinary tract infections caused by extended-spectrum beta-lactamase (ESBL)-producing enterobacteriaInternational Journal Of Clinical Practice, 2012
- Extended-spectrum β-lactamase producing Escherichia coli: changing epidemiology and clinical impactCurrent Opinion in Infectious Diseases, 2010
- Community‐Onset Bacteremia Due to Extended‐Spectrum β‐Lactamase–ProducingEscherichia coli:Risk Factors and PrognosisClinical Infectious Diseases, 2010
- A Multinational Survey of Risk Factors for Infection with Extended‐Spectrum β‐Lactamase–Producing Enterobacteriaceae in Nonhospitalized PatientsClinical Infectious Diseases, 2009
- Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concernThe Lancet Infectious Diseases, 2008
- Prevalence and Antimicrobial Susceptibility Pattern of Extended-Spectrum Beta-Lactamase-Producing Enterobacteriaceae in the United Arab EmiratesMedical Principles and Practice, 2007
- Predictors of Mortality in Patients with Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae : Importance of Inadequate Initial Antimicrobial TreatmentAntimicrobial Agents and Chemotherapy, 2007
- Epidemiology and risk factors for extended-spectrum β-lactamase-producing organisms: A case control study at a tertiary care center in LebanonAmerican Journal of Infection Control, 2005
- Clinical and Microbiological Profile of Urinary Tract Infection at a Tertiary-Care Center in LebanonInfection Control & Hospital Epidemiology, 2004
- Extended-Spectrum -Lactamase-Producing Escherichia coli and Klebsiella pneumoniae: Risk Factors for Infection and Impact of Resistance on OutcomesClinical Infectious Diseases, 2001